Digital Health Funding in APAC in H1 2025 grows by 4%
The first half of 2025 has been a defining moment for Asia-Pacific’s digital health ecosystem, as the region pivots from hype to evidence-backed, AI-driven innovation. While global digital health funding declined by 11%, APAC defied the trend with $1.2B raised across 102 deals, reflecting 4% YoY growth. This performance cements APAC’s role as a resilient and fast-maturing hub for health technology, with standout contributions from Australia ($286M), Hong Kong ($233M), and Japan ($202M).
Artificial intelligence continues to dominate APAC’s innovation landscape, accounting for 63% of all funding, particularly in predictive analytics, AI-powered imaging, and precision medicine. Clusters such as Medical Diagnostics ($279M), Research Solutions ($250M), and Health Management Solutions ($181M) remain strong, while Remote Devices saw a 10x YoY surge to $120M, underscoring the demand for connected care and real-time patient monitoring. With partnerships shifting toward ROI-driven collaborations and therapeutic focus areas like Women’s Health ($313M) and Oncology ($311M) leading the way, APAC is shaping the future of digital health in 2025.
Key Findings – APAC H1 2025
-
AI Dominates APAC Funding: AI ventures captured 63% of APAC funding, with predictive analytics, AI-powered imaging, and research solutions driving adoption.
-
Deal Size Adjustments: The average deal size decreased from $19.3M in Q1 to $15.3M in Q2, as investors opted for more, smaller strategic deals, though the trend remains upward since Q1 2023.
-
Partnership Recalibration: APAC partnerships in H1 2025 account for just 30% of 2024’s total, with Medical Diagnostics (39%) and Health Management Solutions (16%) leading ROI-driven collaborations.
-
Cluster Leaders: Medical Diagnostics ($279M), Research Solutions ($250M), and Health Management Solutions ($181M) dominate funding, while Remote Devices surged 10x YoY to $120M.
-
Therapeutic Focus: Women’s Health ($313M) and Oncology ($311M) lead therapeutic investments, followed by Geriatrics ($280M) and Neurology ($211M).
Why it Matters
APAC’s digital health ecosystem is maturing rapidly, driven by AI integration, clinical validation, and cross-border partnerships. The rise of AI-enabled health solutions across diagnostics, hospital infrastructure, and therapeutic care demonstrates APAC’s strategic importance in shaping global health technology trends.
Explore the Full Report
Gain a deep dive into the global H1 2025 digital health funding trends, cluster performance, and therapeutic priorities, with actionable insights for investors, corporates, and healthcare leaders.
Powered by HealthTech Alpha
The Q2 digital health Funding report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. Leveraging an extensive database of over 15,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyse the critical trends shaping the future of digital health.Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate digital transformation complexities. This collaboration ensures readers gain a comprehensive, evidence-based view of the intersection between digital health and healthcare, equipping them to identify strategic opportunities, assess market dynamics, and stay ahead in this fast-evolving industry.